Everence Capital Management’s Organon & Co OGN Stock Holding History

Everence Capital Management’s Portfolio OGN Stock Details OGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-25,596	Closed	-$184K	–	860
2025 Q4	$184K	Buy	25,596 +13,546	+112%	+$107K	0.01%	756
2025 Q3	$129K	Hold	12,050	–	–	0.01%	792
2025 Q2	$117K	Hold	12,050	–	–	0.01%	779
2025 Q1	$179K	Hold	12,050	–	–	0.01%	758
2024 Q4	$180K	Sell	12,050 -22,620	-65%	-$369K	0.01%	798
2024 Q3	$663K	Hold	34,670	–	–	0.04%	333
2024 Q2	$645K	Hold	34,670	–	–	0.04%	317
2024 Q1	$652K	Buy	34,670 +6,950	+25%	+$119K	0.04%	338
2023 Q4	$400K	Buy	+27,720	New	+$377K	0.03%	469
2022 Q1	–	Sell	-8,704	Closed	-$265K	–	772
2021 Q4	$265K	Sell	8,704 -29,057	-77%	-$946K	0.02%	632
2021 Q3	$1.24M	Buy	+37,761	New	+$1.21M	0.1%	168

Other funds holding OGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

KBG

Kahn Brothers Group New York $633M AUM 39.01% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

PMG

Private Management Group Irvine, California $3.8B AUM 23.19% 1-Year Est. Return

Everence Capital Management's OGN Position: Q1 2026 in Review

Everence Capital Management sold out of Organon & Co (OGN) in Q1 2026, closing a stake of 25,596 shares — an estimated $184K sold.

Everence Capital Management first reported a position in OGN in Q3 2021 and held it in 11 quarters. The position peaked at $1.24M in Q3 2021. 608 funds tracked by Wall St. Rank hold OGN as of Q1 2026.

Everence Capital Management reported no remaining Organon & Co position as of Q1 2026 after selling out during the quarter.
Everence Capital Management sold 25,596 Organon & Co shares in Q1 2026, an estimated $184K.
Everence Capital Management first reported a position in Organon & Co in Q3 2021 and held it in 11 quarters.
Everence Capital Management's Organon & Co position peaked at $1.24M in Q3 2021.
608 funds tracked by Wall St. Rank held Organon & Co as of Q1 2026.

Based on Everence Capital Management's 13F filing for Q1 2026, filed 28 Apr 2026.